Hedge Fund - Palo Alto Investors
Clovis Oncology Inc. (CLVS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $0.66 |
| 2 | 2022 - Q3 (2022-09-30) | $5,324,000 | 0.42% | 4,473,967 | $1.56 |
| 3 | 2022 - Q2 (2022-06-30) | $8,053,000 | 0.7% | 4,473,967 | $1.48 |
| 4 | 2022 - Q1 (2022-03-31) | $9,037,000 | 0.69% | 4,473,967 | $1.96 |
| 5 | 2021 - Q4 (2021-12-31) | $10,834,000 | 0.69% | 3,997,826 | $3.70 |
| 6 | 2021 - Q3 (2021-09-30) | $20,000,000 | 1.2% | 4,484,411 | $4.82 |
| 7 | 2021 - Q2 (2021-06-30) | $26,010,000 | 1.43% | 4,484,411 | $5.86 |
| 8 | 2021 - Q1 (2021-03-31) | $31,481,000 | 1.79% | 4,484,411 | $6.70 |
| 9 | 2020 - Q4 (2020-12-31) | $21,453,000 | 1.12% | 4,469,411 | $5.06 |
| 10 | 2020 - Q3 (2020-09-30) | $26,057,000 | 1.43% | 4,469,411 | $5.98 |
| 11 | 2020 - Q2 (2020-06-30) | $29,440,000 | 1.76% | 4,361,411 | $7.57 |
| 12 | 2020 - Q1 (2020-03-31) | $29,484,000 | 2.46% | 4,635,789 | $8.02 |
| 13 | 2019 - Q4 (2019-12-31) | $52,712,000 | 2.9% | 5,056,286 | $7.27 |
| 14 | 2019 - Q3 (2019-09-30) | $18,553,000 | 1.23% | 4,720,744 | $8.09 |
| 15 | 2019 - Q2 (2019-06-30) | $76,451,000 | 3.71% | 5,141,304 | $18.07 |
| 16 | 2019 - Q1 (2019-03-31) | $130,040,000 | 5.42% | 5,239,304 | $25.07 |
| 17 | 2018 - Q4 (2018-12-31) | $94,098,000 | 5% | 5,239,304 | $20.43 |
| 18 | 2018 - Q3 (2018-09-30) | $153,342,000 | 6.19% | 5,221,026 | $38.72 |
| 19 | 2018 - Q2 (2018-06-30) | $226,168,000 | 9.03% | 4,974,007 | $48.64 |
| 20 | 2018 - Q1 (2018-03-31) | $208,859,000 | 8.93% | 3,955,660 | $58.35 |
| 21 | 2017 - Q4 (2017-12-31) | $231,389,000 | 9.96% | 3,402,781 | $69.92 |
| 22 | 2017 - Q3 (2017-09-30) | $274,357,000 | 11.55% | 3,329,581 | $79.28 |
| 23 | 2017 - Q2 (2017-06-30) | $311,749,000 | 14.55% | 3,329,581 | $61.19 |
| 24 | 2017 - Q1 (2017-03-31) | $247,992,000 | 11.72% | 3,894,963 | $60.79 |
| 25 | 2016 - Q4 (2016-12-31) | $168,978,000 | 9.64% | 3,804,088 | $35.20 |
| 26 | 2016 - Q3 (2016-09-30) | $137,137,000 | 7.96% | 3,804,088 | $21.46 |
| 27 | 2016 - Q2 (2016-06-30) | $52,192,000 | 3.94% | 3,804,088 | $14.62 |
| 28 | 2016 - Q1 (2016-03-31) | $66,458,000 | 5.15% | 3,461,365 | $21.16 |
| 29 | 2015 - Q4 (2015-12-31) | $124,170,000 | 6.91% | 3,547,719 | $64.49 |
| 30 | 2015 - Q3 (2015-09-30) | $285,886,000 | 13.74% | 3,108,808 | $86.54 |
| 31 | 2015 - Q2 (2015-06-30) | $211,010,000 | 9.38% | 2,401,117 | $85.60 |
| 32 | 2015 - Q1 (2015-03-31) | $157,505,000 | 7.78% | 2,121,857 | $70.62 |
| 33 | 2014 - Q4 (2014-12-31) | $117,760,000 | 6.91% | 2,102,857 | $52.56 |
| 34 | 2014 - Q3 (2014-09-30) | $78,099,000 | 5.83% | 1,721,757 | $41.77 |
| 35 | 2014 - Q2 (2014-06-30) | $37,903,000 | 2.82% | 915,321 | $51.50 |
| 36 | 2014 - Q1 (2014-03-31) | $12,947,000 | 1.06% | 186,900 | $73.44 |
| 37 | 2013 - Q4 (2013-12-31) | $11,264,000 | 1.05% | 186,900 | $54.39 |
The displayed share prices are average quarterly stock market prices.